Reactogenicity of a three-dose pertussis acellular vaccine catch-up in children 21-40 months of age. [electronic resource]
- Vaccine Apr 1999
- 2030-5 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.